ATAC-seq profiling assessing the impact of IFNg and Pictilisib on human SqCC/Y1 cells
Ontology highlight
ABSTRACT: To examine differences in chromatin accessibility SqCC/Y1 cells were treated with Pictilisib to inhibit PI3K signaling in combination with DMSO or IFNg for 48 hours and ATAC-seq performed.
ORGANISM(S): Homo sapiens
PROVIDER: GSE137719 | GEO | 2019/09/20
REPOSITORIES: GEO
ACCESS DATA